BeStock  
Stocks › Biotechnology › RXRX

Recursion Pharmaceuticals RXRX

US equityMarket cap rank #2603BiotechnologyAI medical concept stocks
$4.78 +$0.66 (+16.02%)
Pre-market · Oct 6, 4:10 am ET · After hours $4.76 -0.42%
Open$4.16
Prev close$4.12
Day range$4.06 – $4.94
Volume67.28M
Market cap$2.56B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, not just today’s reading.

Technical signals

Trend readStrong uptrend

4 bullish · 1 bearish of 7 signals

IndicatorValueSignalReading
Price vs 20-day average+28.5%BullishTrading above the 20-day average of $3.72
Price vs 50-day average+38.4%BullishTrading above the 50-day average of $3.45
Price vs 200-day average+33.7%BullishTrading above the 200-day average of $3.58
50-day vs 200-day50d below 200dBearishThe 50-day average is below the 200-day average
RSI (14)71.8NeutralOverbought territory (70+); rallies this stretched often pause
MACD (12,26,9)0.25BullishMACD line is above its signal line
Bollinger band position112%NeutralAbove the upper band, an extended move

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

Levels & volatility

Moving averages

AverageLevelPrice vs. it
20-day SMA$3.72+28.5%
50-day SMA$3.45+38.4%
200-day SMA$3.58+33.7%

Recent price levels

LevelPrice
20-day high$4.94
20-day low$3.10
60-day high$4.94
60-day low$2.84
Upper Bollinger band$4.57
Lower Bollinger band$2.87

The 50-day average is currently 3.4% below the 200-day average — consistent with a “death cross” (bearish) configuration.

30-day volatility89.6%
Average true range6.60% of price
Max drawdown (1y)-58.2%
Volume (10d vs 90d)1.27x

Discussion

No comments yet — be the first to weigh in on RXRX.

Leave a comment

Scroll to Top